| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation Research, Vol 38, 362-367, Copyright © 1976 by American Heart Association
ARTICLES |
K Hermsmeyer
The possibility that the vascular muscle cell might contribute to the development of essential hypertension by being more responsive to norepinephrine because of an inherently lower membrane potential (Em) was investigated. Experiments were designed to test the hypothesis that Em of arterial vascular muscle cells from spontaneously hypertensive rats (SHR) are less negative than those from matched Kyoto normotensive rats (KNR). The caudal artery, a muscular, densely innervated regulating artery 300-400 mum in outside diameter, which is activated by graded (nonspiking) depolarization to produce a maintained contraction, was studied. Vascular muscle cells from SHR always had less negative Em than those from KNR at 16 degrees C, but not at 36 degrees C, over a range of K+ concentrations from 2.7 mM to 150 mM. From the relationship between Em and K+ concentration, intracellular K+ concentration ([K+]i) was estimated to be 150 mM for SHR and 170 mM for KNR. The caudal artery undergoes a large depolarization when K+ is removed from the superfusing solution and a transient hyperpolarization that exceeds the calculated EK (potassium equilibrium potential) when K+ is replaced. The magnitude of the hyper-polarization on returning to 30 mM or 50 mM K+ always was greater for vascular muscle of SHR than KNR. The apparently lower [K+]i and more active (compensating) electrogenic ion transport in the SHR vascular muscle cells thus result in an unaltered Em at body temperature in the physiological range of K+ concentrations. However, depolarization by norepinephrine was greater over the middle of the dose-response curve, and this greater depolarization caused the contractions of SHR arteries to be greater. The altered electrogenesis of the SHR vascular muscle cells is postulated to provide a mechanism for the increased reactivity of arteries to norepinephrein in hypertension.
This article has been cited by other articles:
![]() |
J. R. Martens, P. Y. Reaves, D. Lu, M. J. Katovich, K. H. Berecek, S. P. Bishop, M. K. Raizada, and C. H. Gelband Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy PNAS, March 3, 1998; 95(5): 2664 - 2669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Martens and C. H. Gelband Alterations in Rat Interlobar Artery Membrane Potential and K+ Channels in Genetic and Nongenetic Hypertension Circ. Res., August 1, 1996; 79(2): 295 - 301. [Abstract] [Full Text] |
||||
![]() |
R. M. White, C. O. Rivera, and C. B. Davison Differential Contribution of Endothelial Function to Vascular Reactivity in Conduit and Resistance Arteries From Deoxycorticosterone-Salt Hypertensive Rats Hypertension, June 1, 1996; 27(6): 1245 - 1253. [Abstract] [Full Text] |
||||
![]() |
A. M. Sanchez, T. A. Wooldridge, L. E. Boerboom, G. N. Olinger, G. H. Almassi, and N. J. Rusch Comparison of saphenous vein graft relaxation between Plasma-Lyte solution and normal saline solution J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1445 - 1453. [Abstract] [Full Text] |
||||
![]() |
S. M. FRIEDMAN Monovalent and Divalent Ions in Vascular Tissue Ann Intern Med, May 1, 1983; 98(5_Part_2): 753 - 758. [Abstract] [PDF] |
||||
![]() |
M. P. BLAUSTEIN and J. M. HAMLYN Role of a Natriuretic Factor in Essential Hypertension: An Hypothesis Ann Intern Med, May 1, 1983; 98(5_Part_2): 785 - 792. [Abstract] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1976 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |